CRIS Current Research Information System

SAIA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.913
NA - Nord America 8.987
EU - Europa 6.834
AF - Africa 712
SA - Sud America 619
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 2
Totale 27.084
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.807
VN - Vietnam 2.993
SG - Singapore 2.549
CN - Cina 2.245
IT - Italia 1.442
GB - Regno Unito 1.174
DE - Germania 1.117
HK - Hong Kong 685
SE - Svezia 643
NL - Olanda 631
BR - Brasile 454
FR - Francia 416
IN - India 371
RU - Federazione Russa 269
KR - Corea 261
UA - Ucraina 258
IE - Irlanda 250
BD - Bangladesh 190
SC - Seychelles 164
JP - Giappone 160
CI - Costa d'Avorio 158
FI - Finlandia 144
ZA - Sudafrica 127
TG - Togo 113
CA - Canada 101
BG - Bulgaria 94
EE - Estonia 85
NG - Nigeria 83
JO - Giordania 78
CH - Svizzera 67
AR - Argentina 66
PH - Filippine 66
TH - Thailandia 52
BE - Belgio 44
MX - Messico 43
PL - Polonia 42
AT - Austria 40
IQ - Iraq 38
IR - Iran 29
TR - Turchia 28
TW - Taiwan 27
PK - Pakistan 26
ES - Italia 23
ID - Indonesia 23
SA - Arabia Saudita 20
CL - Cile 19
PY - Paraguay 19
EC - Ecuador 18
EG - Egitto 18
LT - Lituania 18
CO - Colombia 16
RO - Romania 16
AU - Australia 14
UZ - Uzbekistan 13
HR - Croazia 11
GR - Grecia 10
UY - Uruguay 10
JM - Giamaica 9
MA - Marocco 9
MY - Malesia 9
DK - Danimarca 8
OM - Oman 8
PE - Perù 8
VE - Venezuela 8
KZ - Kazakistan 7
TN - Tunisia 7
KE - Kenya 6
GT - Guatemala 5
PT - Portogallo 5
SI - Slovenia 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HN - Honduras 4
IL - Israele 4
LV - Lettonia 4
MK - Macedonia 4
MN - Mongolia 4
NI - Nicaragua 4
NP - Nepal 4
SN - Senegal 4
CZ - Repubblica Ceca 3
ET - Etiopia 3
HU - Ungheria 3
LB - Libano 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
GA - Gabon 2
GE - Georgia 2
ML - Mali 2
MM - Myanmar 2
MW - Malawi 2
PR - Porto Rico 2
PS - Palestinian Territory 2
TZ - Tanzania 2
AL - Albania 1
Totale 27.058
Salva come PNG Salva come JPEG
Città #
Singapore 1.714
Ashburn 1.083
Southend 981
Ho Chi Minh City 702
Fairfield 641
Hong Kong 640
Chandler 624
Hanoi 618
San Jose 611
Hefei 494
Santa Clara 471
Frankfurt am Main 408
Eygelshoven 337
Wilmington 304
Seattle 301
Woodbridge 299
Houston 291
Beijing 285
Ann Arbor 268
Princeton 263
Dublin 249
Seoul 225
Boardman 219
Bologna 217
Cambridge 213
Dong Ket 205
New York 198
Los Angeles 185
Abidjan 157
Lauterbourg 155
Jacksonville 146
Tokyo 131
Milan 118
Turin 115
Lomé 113
Da Nang 106
Westminster 106
Berlin 99
Padova 94
Nanjing 92
Sofia 89
Helsinki 84
São Paulo 84
Buffalo 81
Council Bluffs 81
Abeokuta 80
Haiphong 80
Bremen 79
Amman 78
Munich 71
Dallas 67
Rome 65
Bern 56
Jinan 54
San Diego 54
Redondo Beach 53
Changsha 49
Guangzhou 47
Shenyang 47
Bengaluru 44
Shanghai 44
Saint Petersburg 42
Dearborn 41
Turku 41
Brussels 39
Johannesburg 39
Nanchang 37
Biên Hòa 34
Hebei 34
Tianjin 34
London 33
Chicago 32
Florence 30
Hải Dương 30
Toronto 30
Can Tho 29
Phoenix 29
Pune 28
The Dalles 28
Yubileyny 28
Falkenstein 27
Montreal 27
Mülheim 27
Warsaw 26
Medford 25
Quận Bình Thạnh 24
Bangkok 23
Ha Long 23
Paris 23
Atlanta 22
Nuremberg 22
Zhengzhou 22
Jiaxing 21
Olalla 21
Shenzhen 21
Taizhou 21
Vienna 21
Hangzhou 20
Mexico City 20
Orem 20
Totale 16.959
Salva come PNG Salva come JPEG
Nome #
[Prevalence of degenerative aortic valve stenosis in the elderly: results of a large community-based epidemiological study] 927
Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI 280
Redo-Transcatheter Aortic Valve Implantation Using the SAPIEN 3/Ultra Transcatheter Heart Valves—Expert Consensus on Procedural Planning and Techniques 272
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 266
A Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry). 265
The role of the vascular surgeon in transcatheter aortic valve implantation 264
Is Pulmonary Artery Pulsatility Index (PAPi) a Predictor of Outcome after Pulmonary Endarterectomy? 262
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 257
Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non–ST-Segment–Elevation Myocardial Infarction 256
[The HEAT-PPCI study] 252
[Cognitive and quality of life trajectory after either surgical or transcatheter aortic valve replacement in high-risk patients] 249
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 248
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 242
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 235
La qualità di vita dopo impianto transcatetere di valvola aortica: revisione e valutazione critica della letteratura 232
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 232
Cognitive functions: Evaluation and changes after transcatheter aortic valve implantation in elderly patients 231
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 228
Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study) 224
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 222
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) 220
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement 216
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 216
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 212
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 207
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 205
Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery 205
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 205
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 201
Prognostic significance of shockable and non-shockable cardiac arrest in ST-segment elevation myocardial infarction patients undergoing primary angioplasty 200
La rete per il trattamento dell’infarto miocardico acuto con sopraslivellamento del tratto ST in Italia. Risultati della rilevazione RETE IMA WEB 199
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 197
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcome 196
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation 196
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 194
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 194
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 193
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 191
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 190
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 188
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 188
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 186
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 185
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 185
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 185
Elevati livelli pre-procedurali della proteina C-reattiva predicono la mortalita a 9 mesi dall'angioplastica del tronco comune non protetto. 184
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 184
Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods. 181
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 180
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 179
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 179
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 178
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 178
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 176
Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials 176
Transcatheter aortic‐valve implantation with or without on‐site cardiac surgery: The TRACS trial 174
Simultaneous versus staged approach in transcatheter aortic valve implantation for severe stenosis and endovascular aortic repair for thoracic and abdominal aortic aneurysm 173
Transfemoral Transcatheter Aortic Valve Implantation at Hospitals Without On-Site Cardiac Surgery (TAVI at Home): A Multicenter Prospective Interventional Study 173
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 173
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 173
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 172
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 171
Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. 169
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 169
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 169
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 168
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study 168
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 167
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 165
A rescue transcatheter solution for early sutureless basal ring infolding 162
Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation. 162
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 162
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 161
How should i treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation? 161
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 160
Predicting and improving outcomes of transcatheter aortic valve replacement in older adults and the elderly 160
Left ventricular recovery after ST-elevation myocardial infarction in patients treated with primary coronary angioplasty and abciximab or tirofiban 159
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry 159
Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease 159
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 158
[Bioresorbable vascular scaffolds: clinical experience of the Emilia-Romagna Region, Italy] 156
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 156
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 156
Twelve-Month Outcome of Patients with an Established Indication for Oral Anticoagulation Undergoing Coronary Artery Stenting and Stratified by the Baseline Risk of Bleeding. Insights from the Warfarin and Coronary Stenting (War-Stent) Registry 156
Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abcximab (FATA) in ST-elevation myocardial infarction trial 155
Transcatheter Mitral Valve-in-Valve Dislocation: A Rescue Strategy 155
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention 154
Repeated Aortic Balloon Valvuloplasty in Elderly Patients With Aortic Stenosis Who Are Not Candidates for Definitive Treatment 153
Standard ECG to predict culprit left main disease in unselected patients with non ST-segment elevation acute coronary syndrome 153
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 152
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 151
The safety of drug-eluting stents. 148
Correlation between aortic root dimension and coronary ectasia 148
Diagnostic performance of standard electrocardiogramfor prediction of site of coronary occlusion in unselected anterior STEMI patients 147
Coronary ectasia in different scenarios, primarily in myocardial infarction with nonobstructive coronary artery disease 146
Transcatheter aortic valve implantation for severe autograft regurgitation after Ross operation. 146
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 145
Recapture of the Sapien-3 Delivery System After Transversal Balloon Rupture Using a Whole Percutaneous Femoral Approach 144
Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR in Sievers Type 1 Bicuspid Aortic Valves 142
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 142
Totale 19.545
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.009
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021603 0 0 0 0 0 0 0 0 0 0 0 603
2021/20222.336 179 116 132 202 182 119 46 155 80 203 505 417
2022/20233.095 270 438 165 379 251 227 75 183 575 84 271 177
2023/2024919 77 127 41 103 66 258 36 58 23 64 25 41
2024/20254.316 190 533 331 283 642 226 195 121 115 420 252 1.008
2025/202611.592 1.334 1.114 815 846 1.015 820 1.498 440 1.966 820 547 377
Totale 27.635